Vik Meadows - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Vik Meadows

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

Ebiomedicine|September 17, 2019

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2<sup>-/-</sup> mouse model of primary sclerosing cholangitis (PSC)Tianhao Zhou, Konstantina Kyritsi, Nan Wu, et al.

Hepatology (Baltimore, Md.)|August 2, 2020

Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver InjuryNan Wu, Leonardo Baiocchi, Tianhao Zhou, et al.

Gut|June 15, 2022

Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSCMuyiwa Awoniyi, Jeremy Wang, Billy Ngo, et al.

Hepatology Communications|May 16, 2025

Deletion of hepatic FXR leads to more severe MASH development in female miceZakiyah R Henry, Laura Armstrong, Syeda Maliha, et al.

Pageof 5

Search research articles

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

Ebiomedicine|September 17, 2019

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2<sup>-/-</sup> mouse model of primary sclerosing cholangitis (PSC)Tianhao Zhou, Konstantina Kyritsi, Nan Wu, et al.

Hepatology (Baltimore, Md.)|August 2, 2020

Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver InjuryNan Wu, Leonardo Baiocchi, Tianhao Zhou, et al.

Gut|June 15, 2022

Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSCMuyiwa Awoniyi, Jeremy Wang, Billy Ngo, et al.

Hepatology Communications|May 16, 2025

Deletion of hepatic FXR leads to more severe MASH development in female miceZakiyah R Henry, Laura Armstrong, Syeda Maliha, et al.

Pageof 5